The Oxybutynin Chloride Extended Rel, cataloged under National Stock Number 6505-01-569-3642, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Avkare Llc. Government technical data includes 1 specification, cited from the U.S. Government catalog. The record lists 2 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 1 additional reference document (drawings, advisory and superseded references) is recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-569-3642 |
| Primary Part Number | NDC42291-0633-01 |
| Item Name | Oxybutynin Chloride Extended Rel |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Avkare Llc |
| Status | ACTIVE |
| Protective Storage Feature | CONTROLLED ROOM TEMPERATURE |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| NDC42291-0633-01 PRIMARY | Avkare Llc (USA) |
| NDC62175-0270-37 PRIMARY | Kremers Urban Pharmaceuticals Inc. Dba Kremers Urban Pharmaceuticals Inc (USA) |
| Reference | Meaning |
|---|---|
| NDC00378-6605-01 | 5/9 Secondary reference Mylan Pharmaceuticals Inc |
NSN 6505-01-569-3642 is a Oxybutynin Chloride Extended Rel, manufactured by Avkare Llc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-569-3642 has 2 manufacturer part numbers on file: NDC42291-0633-01 (Avkare Llc), NDC62175-0270-37 (Kremers Urban Pharmaceuticals Inc. Dba Kremers Urban Pharmaceuticals Inc).
Key specifications for NDC42291-0633-01: Special Features: 5 MG OXYBUTYNIN CHLORIDE ACTIVE INGREDIENT; BOTTLE OF 100 EXTENDED RELEASE TABLETS; Protective Storage Feature: CONTROLLED ROOM TEMPERATURE; Part Name Assigned by Controlling Agency: OXYBUTYNIN CHLORIDE EXTENDED RELEASE TABLETS 5MG 100S. 1 specification is documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.